The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Increased Interleukin (IL)-1β Messenger Ribonucleic Acid Expression in β-Cells of Individuals with Type 2 Diabetes and Regulation of IL-1β in Human Islets by Glucose and Autostimulation
Open accessAbstract
Context: Elevated glucose levels impair islet function and survival, and it has been proposed that intraislet expression of IL-1β contributes to glucotoxicity. Objective: The objective was to investigate IL-1β mRNA expression in near-pure β-cells of patients with type 2 diabetes (T2DM) and study the regulation of IL-1β by glucose in isolated human islets. Methods: Laser capture microdissection was performed to isolate β-cells from pancreas sections of 10 type 2 diabetic donors and nine controls, and IL-1β mRNA expression was analyzed using gene arrays and PCR. Cultured human islets and fluorescence-activated cell sorter-purified human β-cells were used to study the regulation of IL-1β expression by glucose and IL-1β. Results: Gene array analysis of RNA from β-cells of individuals with T2DM revealed increased expression of IL-1β mRNA. Real-time PCR confirmed increased IL-1β expression in six of 10 T2DM samples, with minimal or no expression in nine control samples. In cultured human islets, IL-1β mRNA and protein expression was induced by high glucose and IL-1β autostimulation and decreased by the IL-1 receptor antagonist IL-1Ra. The glucose response was negatively correlated with basal IL-1β expression levels. Autostimulation was transient and nuclear factor-κB dependent. Glucose-induced IL-1β was biologically active and stimulated IL-8 release. Low picogram per milliliter concentrations of IL-1β up-regulated inflammatory factors IL-8 and IL-6. Conclusion: Evidence that IL-1β mRNA expression is up-regulated in β-cells of patients with T2DM is presented, and glucose-promoted IL-1β autostimulation may be a possible contributor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Emmert-Buck, M. R., Bonner, R. F., Smith, P. D., Chuaqui, R. F., Zhuang, Z., Goldstein, S. R., Weiss, R. A., & Liotta, L. A. (1996) · Science · doi:10.1126/science.274.5289.998 · Cited by 2,534
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Self-citationGlucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,114
Self-citationINTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in Biology
Arend, W. P., Malyak, M., Guthridge, C. J., & Gabay, C. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.27 · Cited by 1,071
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215318 · Cited by 1,005
Self-citationA choice of death - the signal-transduction of immune-mediated beta-cell apoptosis
Eizirik, D. L., & Mandrup-Poulsen, T. (2001) · Diabetologia · doi:10.1007/s001250100021 · Cited by 888
Inflammatory caspases and inflammasomes: master switches of inflammation
Martinon, F., & Tschopp, J. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402038 · Cited by 820
The interleukin‐1 family: 10 years of discovery 1
Dinarello, C. A. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.15.8001745 · Cited by 783
Increased Number of Islet-Associated Macrophages in Type 2 Diabetes
Ehses, J. A., Perren, A., Eppler, E., Ribaux, P., Pospisilik, J. A., Maor-Cahn, R., Gueripel, X., Ellingsgaard, H., Schneider, M. K. J., Biollaz, G., et al. (2007) · Diabetes · doi:10.2337/db06-1650 · Cited by 783
Self-citationThe role of interleukin-1 in the pathogenesis of IDDM
Mandrup-Poulsen, T. (1996) · Diabetologia · doi:10.1007/bf00400649 · Cited by 543
Dinarello, C. A., Ikejima, T., Warner, S. J. C., Orencole, S. F., Lonnemann, G., Cannon, J. G., & Libby, P. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.6.1902 · Cited by 537
Mechanisms of β-Cell Death in Type 2 Diabetes
Donath, M. Y., Ehses, J. A., Maedler, K., Schumann, D. M., Ellingsgaard, H., Eppler, E., & Reinecke, M. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s108 · Cited by 444
Self-citationInflammatory mediators and islet ?-cell failure: a link between type 1 and type 2 diabetes
Donath, M. Y., St�rling, J., Maedler, K., & Mandrup-Poulsen, T. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0450-y · Cited by 422
Self-citationCXC chemokines in angiogenesis
Strieter, R. M., Burdick, M. D., Gomperts, B. N., Belperio, J. A., & Keane, M. P. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.04.007 · Cited by 414
Donath, M. Y., Gross, D. J., Cerasi, E., & Kaiser, N. (1999) · Diabetes · doi:10.2337/diabetes.48.4.738 · Cited by 405
Self-citationAn immune origin of type 2 diabetes?
Kolb, H., & Mandrup-Poulsen, T. (2005) · Diabetologia · doi:10.1007/s00125-005-1764-9 · Cited by 394
The Role of the Interleukin-1–Receptor Antagonist in Blocking Inflammation Mediated by Interleukin-1
Dinarello, C. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431011 · Cited by 373
Leahy, J. L., Cooper, H. E., Deal, D. A., & Weir, G. C. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112389 · Cited by 292
Self-citationResponse of Human Islets to Isolation Stress and the Effect of Antioxidant Treatment
Bottino, R., Balamurugan, A. N., Tse, H., Thirunavukkarasu, C., Ge, X., Profozich, J., Milton, M., Ziegenfuss, A., Trucco, M., & Piganelli, J. D. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2559 · Cited by 277
Inducible interleukin-1 gene expression in human vascular smooth muscle cells.
Libby, P., Ordovas, J. M., Birinyi, L. K., Auger, K. R., & Dinarello, C. A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112732 · Cited by 258
Arend, W. P., Malyak, M., Smith, M. F., Whisenand, T. D., Slack, J. L., Sims, J. E., Giri, J. G., & Dower, S. K. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.10.4766 · Cited by 241
Proliferation of sorted human and rat beta cells
Parnaud, G., Bosco, D., Berney, T., Pattou, F., Kerr-Conte, J., Donath, M. Y., Bruun, C., Mandrup-Poulsen, T., Billestrup, N., & Halban, P. A. (2007) · Diabetologia · doi:10.1007/s00125-007-0855-1 · Cited by 232
Self-citationHuman interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells.
Warner, S. J., Auger, K. R., & Libby, P. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.5.1316 · Cited by 222
Biological role of interleukin 1 receptor antagonist isoforms
Arend, W. P., & Guthridge, C. J. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.suppl_1.i60 · Cited by 201
Johansson, U., Olsson, A., Gabrielsson, S., Nilsson, B., & Korsgren, O. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01392-5 · Cited by 166
Potential Role of Resident Islet Macrophage Activation in the Initiation of Autoimmune Diabetes
Arnush, M., Scarim, A. L., Heitmeier, M. R., Kelly, C. B., & Corbett, J. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.6.2684 · Cited by 161
Identification and Purification of Functional Human β-cells by a New Specific Zinc-fluorescent Probe
Lukowiak, B., Vandewalle, B., Riachy, R., Kerr-Conte, J. A., Gmyr, V., Belaich, S., Lefèbvre, J., & Pattou, F. N. (2001) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540104900412 · Cited by 152
Self-citationWelsh, N., Cnop, M., Kharroubi, I., Bugliani, M., Lupi, R., Marchetti, P., & Eizirik, D. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3238 · Cited by 135
Matsuda, T., Omori, K., Vuong, T., Pascual, M., Valiente, L., Ferreri, K., Todorov, I., Kuroda, Y., Smith, C. V., KANDEEL, F. R., et al. (2005) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2004.00716.x · Cited by 112
Slack, J. L., McMahan, C. J., Waugh, S. M., Schooley, K., Spriggs, M. K., Sims, J. E., & Dower, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53806-0 · Cited by 108
Orencole, S. F., & Dinarello, C. A. (1989) · Cytokine · doi:10.1016/1043-4666(89)91044-2 · Cited by 88
Association of IL-1ra and Adiponectin With C-Peptide and Remission in Patients With Type 1 Diabetes
Pfleger, C., Mortensen, H. B., Hansen, L., Herder, C., Roep, B. O., Hoey, H., Aanstoot, H., Kočova, M., Schloot, N. C., & on behalf of the Hvidøre Study Group on Childhood Diabetes (2008) · Diabetes · doi:10.2337/db07-1697 · Cited by 87
The Fas pathway is involved in pancreatic β cell secretory function
Schumann, D., Maedler, K., Franklin, I., Konrad, D., Størling, J., Böni‐Schnetzler, M., Gjinovci, A., Kurrer, M. O., Gauthier, B. R., Bosco, D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611487104 · Cited by 78
Self-citationMarselli, L., Thorne, J. T., Ahn, Y., Omer, A., Sgroi, D. C., Libermann, T. A., Otu, H. H., Sharma, A., Bonner‐Weir, S., & Weir, G. C. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0931 · Cited by 78
Self-citationAutocrine Induction of the Human Pro-IL-1β Gene Promoter by IL-1β in Monocytes
Toda, Y., Tsukada, J., Misago, M., Kominato, Y., Auron, P. E., & Tanaka, Y. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1984 · Cited by 68
Pancreatic β-Cell Damage Mediated by β-Cell Production of Interleukin-1
Heitmeier, M. R., Arnush, M., Scarim, A. L., & Corbett, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009159200 · Cited by 64
Weksler‐Zangen, S., Raz, I., Lenzen, S., Jörns, A., Ehrenfeld, S., Amir, G., Oprescu, A. I., Yagil, Y., Yagil, C., Zangen, D., et al. (2007) · Diabetes · doi:10.2337/db07-0520 · Cited by 57
Ribaux, P., Ehses, J. A., Lin-Marq, N., Carrozzino, F., Böni‐Schnetzler, M., Hammar, E. B., Irminger, J.-C., Donath, M. Y., & Halban, P. A. (2007) · Endocrinology · doi:10.1210/en.2007-0325 · Cited by 54
Self-citationGmyr, V., Belaich, S., Muharram, G., Lukowiak, B., Vandewalle, B., Pattou, F. N., & Kerr-Conte, J. A. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.125 · Cited by 40
Self-citationBeta cell death in hyperglycaemic Psammomys obesus is not cytokine-mediated
Jörns, A., Rath, K., Bock, O., & Lenzen, S. (2006) · Diabetologia · doi:10.1007/s00125-006-0413-2 · Cited by 29
Cited by
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Self-citationImmunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
Sterile inflammation: sensing and reacting to damage
Chen, G. Y., & Nuñez, G. (2010) · Nature Reviews Immunology · doi:10.1038/nri2873 · Cited by 3,051
The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
Tsalamandris, S., Antonopoulos, A. S., Oikonomou, E., Papamikroulis, G.-A., Vogiatzi, G., Papaioannou, S., Deftereos, S., & Tousoulis, D. (2019) · European Cardiology Review · doi:10.15420/ecr.2018.33.1 · Cited by 1,381
Masters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330
Metadata
- Authors
- Böni-Schnetzler, M., Thorne, J., Parnaud, G., Marselli, L., Ehses, J. A., Kerr-Conte, J., Pattou, F., Halban, P. A., Weir, G. C., & Donath, M. Y.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-10-01
- Volume
- 93
- Issue
- 10
- Pages
- 4065-4074
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1966977991
- Cited by
- 320
- References
- 41
- FWCI
- 20.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.